Article ; Online: SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease.
2021 Volume 73, Issue 2, Page(s) 243–254
Abstract: ... CoV-2 infection could cause Graves' disease (autoimmune hyperthyroidism) in post-COVID-19 patients ... induced Graves' disease and the pivotal role of autoimmune factors in inducing the disease. The review ... a challenge to the human race. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was shown ...
| Abstract | Coronavirus disease 2019 (COVID-19) advances to affect every part of the globe and remains a challenge to the human race. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was shown to affect many organs and organ systems including the thyroid gland as these parts highly express angiotensin-converting enzyme 2 (ACE2) protein, which functions as a receptor for initially entering the virus into the cells. Furthermore, some categories of the population including older people and persons with comorbidities are prone to be more vulnerable to COVID-19 and its complications. Recent reports showed that SARS-CoV-2 infection could cause Graves' disease (autoimmune hyperthyroidism) in post-COVID-19 patients. Factors that may boost the mortality risk of COVID-19 patients are not completely known yet and a clear perception of the group of vulnerable people is also essential. This review briefly summarizes the features of Graves' disease such as symptoms, risk factors, including environmental, genetic, immunological, and other factors, associated disorders, and therapeutic options. It comprehensively describes the recent advances in SARS-CoV-2-induced Graves' disease and the pivotal role of autoimmune factors in inducing the disease. The review also discusses the possible risks of SARS-CoV-2 infection and associated COVID-19 in people with hyperthyroidism. Furthermore, it explains thyroid disease and its association with the severity of COVID-19. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Aged ; COVID-19 ; Comorbidity ; Graves Disease/epidemiology ; Humans ; Peptidyl-Dipeptidase A ; Risk Factors ; SARS-CoV-2 | |||||
| Chemical Substances | Peptidyl-Dipeptidase A (EC 3.4.15.1) | |||||
| Language | English | |||||
| Publishing date | 2021-06-09 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Review | |||||
| ZDB-ID | 1194484-5 | |||||
| ISSN | 1559-0100 ; 1355-008X ; 0969-711X | |||||
| ISSN (online) | 1559-0100 | |||||
| ISSN | 1355-008X ; 0969-711X | |||||
| DOI | 10.1007/s12020-021-02770-6 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 3884: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.